Xcelerating the growth, success and full potential of MedTech development and Healthcare Delivery with End to End control.
Xcelerate seeks to acquire rather than develop its technology / healthcare delivery. We understand that engineering advancements in non-medical fields often have unrealized applications in medical technology & clinical care and the silos existing between advanced engineering and medicine have been poorly bridged. Xcelerate is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and its application to clinical care.
$XCRT Today we announced the commencement of the nationalization process for our two PCT international patent applications:
PCT/US2023/015755 & PCT/US2023/016194.
Read more:
$XCRT Click here to access Form S-1/A filed on 7/31/2024:
https://xcelerate.global/wp-content/uploads/2024/07/Xcelerate_FORM-S-1A.pdf
$XCRT PR link: InvestmentPitch Media interview with our founder & CEO Mike O'Shea - @newsfile_corp
